TIEN LIANG BIOTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.35 TWD | +2.72% |
|
+12.11% | +212.76% |
| Sales 2022 | 529M 16.4M 1.29B | Sales 2023 | 460M 14.27M 1.12B | Capitalization | 664M 20.59M 1.62B |
|---|---|---|---|---|---|
| Net income 2022 | 59M 1.83M 144M | Net income 2023 | 17M 527K 41.38M | EV / Sales 2022 | 1.33 x |
| Net cash position 2022 | 6.44M 200K 15.69M | Net cash position 2023 | 71.34M 2.21M 174M | EV / Sales 2023 | 1.29 x |
| P/E ratio 2022 |
11.9
x | P/E ratio 2023 |
37.4
x | Employees | 65 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.31% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.72% | ||
| 1 week | +12.11% | ||
| Current month | +20.61% | ||
| 1 month | +48.69% | ||
| 3 months | +214.93% | ||
| 6 months | +225.09% | ||
| Current year | +212.76% |
1 week
39.40
47.80
1 month
29.2547.80
Current year
13.9047.80
1 year
13.2547.80
3 years
10.2047.80
5 years
7.6647.80
10 years
7.6647.80
| Managers | Title | Age | Since |
|---|---|---|---|
Yuan Chang Chi
CEO | Chief Executive Officer | - | 25/06/17 |
Chun Hsiung Kuo
DFI | Director of Finance/CFO | - | 09/06/19 |
Hsi Tsung Shen
CHM | Chairman | - | 27/06/02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hsi Tsung Shen
CHM | Chairman | - | 27/06/02 |
Yuan Chang Chi
CEO | Chief Executive Officer | - | 25/06/17 |
Wen Feng Hsiao
BRD | Director/Board Member | - | 30/03/05 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/05/24 | 45.35 | +2.72% | 6,054,731 |
| 23/05/24 | 44.15 | -1.45% | 8,616,415 |
| 22/05/24 | 44.8 | +9.94% | 3,748,242 |
| 21/05/24 | 40.75 | -0.61% | 1,664,054 |
| 20/05/24 | 41 | +1.36% | 2,647,811 |
End-of-day quote Taipei Exchange, May 23, 2024
More quotes
Tien Liang BioTech Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, wholesale and retail of health food products. The Company is also involved in the import, wholesale and retail of western medicines, as well as the manufacture and sales of traditional Chinese medicines. The Company also provides active pharmaceutical ingredients (APIs), biopharmaceuticals and others. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +212.76% | 64.39M | |
| +38.51% | 727B | |
| +33.05% | 599B | |
| -6.23% | 354B | |
| +18.78% | 328B | |
| +1.35% | 277B | |
| +16.00% | 243B | |
| +8.09% | 205B | |
| -5.77% | 203B | |
| +6.19% | 164B |
- Stock Market
- Equities
- 4127 Stock
